Zadaxin® is the commercial brand name of Thymalfasin for Injection, a synthetic thymus-derived immunomodulator developed by SciClone Pharmaceuticals. It regulates T-cell function and enhances the body’s cellular immune response. Main IndicationsAdjuvant treatment of chronic hepatitis B, as well as immunomodulation…
Vfend® is the commercial brand name of Voriconazole Tablets, an orally active triazole antifungal agent developed by Pfizer. It inhibits fungal cytochrome P450-dependent 14α-sterol demethylase to block ergosterol synthesis, exerting broad-spectrum antifungal activity. Main IndicationsTreatment of invasive aspergillosis, serious invasive…
Folotyn® is the commercial brand name of Pralatrexate Injection, an anti-folate anti-metabolite developed by Mundipharma. It inhibits dihydrofolate reductase and other folate-dependent enzymes to block DNA synthesis and induce tumor cell death. Main IndicationsTreatment of relapsed or refractory peripheral T-cell…
Sifrol® is the commercial brand name of Pramipexole Dihydrochloride Sustained-Release Tablets, an orally active non-ergot dopamine agonist developed by Boehringer Ingelheim. It stimulates dopamine receptors to improve motor symptoms and related complications of Parkinson’s disease. Main IndicationsTreatment of idiopathic Parkinson’s…
Cymbalta® is the commercial brand name of Duloxetine Hydrochloride Enteric Capsules, an orally active serotonin-norepinephrine reuptake inhibitor (SNRI) developed by Eli Lilly and Company. It blocks serotonin and norepinephrine reuptake to regulate neurotransmitter levels and improve mood and pain perception.…
Kisunla® is the commercial brand name of Donanemab Injection, a humanized monoclonal antibody developed by Eli Lilly and Company. It targets and clears accumulated amyloid-beta plaques in the brain to slow the progression of Alzheimer’s disease. Main IndicationsTreatment of adult…
Dupixent® is the commercial brand name of Dupilumab Injection, a fully human monoclonal antibody against IL-4Rα developed by Sanofi. It blocks IL-4 and IL-13 signaling to suppress type 2 inflammatory responses. Main IndicationsModerate-to-severe atopic dermatitis, uncontrolled asthma, chronic rhinosinusitis with…
Evrysdi® is the commercial brand name of Risdiplam powder for oral solution, an orally administered splicing modifier developed by Roche. It modulates SMN2 gene splicing to elevate functional SMN protein level for spinal muscular atrophy treatment. Main IndicationsTreatment of spinal…
TEVIMBRA® is the overseas commercial brand name. Its generic English name is Tislelizumab Injection, a humanized anti-PD-1 IgG4 monoclonal antibody independently developed by BeiGene. It blocks PD-1/PD-L1 binding to reactivate body’s own anti-tumor immune T cells, with modified Fc segment…
Akeega® is the commercial brand name of Niraparib Tosylate and Abiraterone Acetate Tablets, an oral fixed-dose combination drug developed by Johnson & Johnson. It combines PARP inhibitor niraparib and androgen synthesis inhibitor abiraterone to block dual pathogenic pathways of advanced…